MX356851B - Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos. - Google Patents

Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos.

Info

Publication number
MX356851B
MX356851B MX2015009364A MX2015009364A MX356851B MX 356851 B MX356851 B MX 356851B MX 2015009364 A MX2015009364 A MX 2015009364A MX 2015009364 A MX2015009364 A MX 2015009364A MX 356851 B MX356851 B MX 356851B
Authority
MX
Mexico
Prior art keywords
tungsten
treatment
salts
female infertility
diabetic mammals
Prior art date
Application number
MX2015009364A
Other languages
English (en)
Other versions
MX2015009364A (es
Inventor
Canals Almazán Ignacio
Arbat Bugié Agnès
Original Assignee
Oxolife Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49999950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX356851(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oxolife Sl filed Critical Oxolife Sl
Publication of MX2015009364A publication Critical patent/MX2015009364A/es
Publication of MX356851B publication Critical patent/MX356851B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physiology (AREA)

Abstract

La invención actual comprende el uso de una cantidad terapéuticamente efectiva de una sal de tungsteno (VI) con un grupo catiónico farmacéuticamente o veterinariamente aceptable, o un solvato de la sal, para la preparación de un producto medicinal para el tratamiento de infertilidad femenina en mamíferos no diabéticos.
MX2015009364A 2013-01-22 2014-01-21 Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos. MX356851B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201330071A ES2478790B1 (es) 2013-01-22 2013-01-22 Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
PCT/EP2014/051141 WO2014114644A1 (en) 2013-01-22 2014-01-21 Use of tungsten (vi) salts for the treatment of female infertility in non-diabetic mammals

Publications (2)

Publication Number Publication Date
MX2015009364A MX2015009364A (es) 2016-03-08
MX356851B true MX356851B (es) 2018-06-18

Family

ID=49999950

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009364A MX356851B (es) 2013-01-22 2014-01-21 Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos.

Country Status (27)

Country Link
US (1) US9675638B2 (es)
EP (1) EP2948156B1 (es)
JP (1) JP6045721B2 (es)
KR (1) KR102182563B1 (es)
CN (1) CN105188721B (es)
AU (1) AU2014209987B2 (es)
BR (1) BR112015017483A2 (es)
CA (1) CA2898953C (es)
CL (1) CL2015002047A1 (es)
CY (1) CY1118287T1 (es)
DK (1) DK2948156T3 (es)
ES (2) ES2478790B1 (es)
HK (1) HK1217442A1 (es)
HR (1) HRP20161611T1 (es)
HU (1) HUE031910T2 (es)
IL (1) IL240062B (es)
LT (1) LT2948156T (es)
MX (1) MX356851B (es)
NZ (1) NZ710583A (es)
PL (1) PL2948156T3 (es)
PT (1) PT2948156T (es)
RS (1) RS55418B1 (es)
RU (1) RU2635507C2 (es)
SG (1) SG11201505701WA (es)
SI (1) SI2948156T1 (es)
SM (1) SMT201700018B (es)
WO (1) WO2014114644A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
ES2639588B1 (es) * 2014-05-21 2018-09-06 Oxolife, S.L. Uso de una sal de tungsteno (VI) para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético
PT3173382T (pt) * 2014-07-21 2023-03-10 Oxolife Sl Sais de tungsténio (vi) utilizados para tratar infertilidade, para estimular a fertilidade e a reprodução normal num mamífero fêmea não diabético, e para melhorar a eficácia das técnicas de reprodução assistida
EP4368577A1 (en) * 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2141361C1 (ru) * 1998-03-12 1999-11-20 Пермская государственная медицинская академия Способ лечения ановуляторного бесплодия при ожирении
ES2187276B1 (es) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
CA2500897A1 (en) * 2002-10-02 2004-04-15 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
RU2270684C1 (ru) * 2005-01-20 2006-02-27 Анатолий Григорьевич Гриценко Лекарственный препарат "витасорб"
CN101237875B (zh) * 2005-07-29 2011-07-13 巴塞罗纳大学 用于治疗神经退行性障碍特别是阿尔茨海默病或精神分裂症的含钨盐（vi）的药物组合物
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof

Also Published As

Publication number Publication date
BR112015017483A2 (pt) 2017-07-11
IL240062A0 (en) 2015-09-24
IL240062B (en) 2018-11-29
RS55418B1 (sr) 2017-04-28
KR102182563B1 (ko) 2020-11-25
JP6045721B2 (ja) 2016-12-14
CY1118287T1 (el) 2017-06-28
PL2948156T3 (pl) 2017-07-31
WO2014114644A1 (en) 2014-07-31
PT2948156T (pt) 2016-11-30
LT2948156T (lt) 2016-12-27
US20150359820A1 (en) 2015-12-17
AU2014209987A1 (en) 2016-01-21
MX2015009364A (es) 2016-03-08
HRP20161611T1 (hr) 2017-01-27
CN105188721A (zh) 2015-12-23
HK1217442A1 (zh) 2017-01-13
HUE031910T2 (en) 2017-08-28
SG11201505701WA (en) 2015-08-28
RU2635507C2 (ru) 2017-11-13
CL2015002047A1 (es) 2016-01-04
US9675638B2 (en) 2017-06-13
JP2016505057A (ja) 2016-02-18
CA2898953A1 (en) 2014-07-31
DK2948156T3 (da) 2017-01-02
ES2611776T3 (es) 2017-05-10
EP2948156A1 (en) 2015-12-02
NZ710583A (en) 2016-06-24
RU2015135578A (ru) 2017-03-02
SI2948156T1 (sl) 2017-02-28
EP2948156B1 (en) 2016-10-26
KR20150130992A (ko) 2015-11-24
AU2014209987B2 (en) 2016-09-01
SMT201700018B (it) 2017-03-08
ES2478790A1 (es) 2014-07-22
CA2898953C (en) 2018-01-02
ES2478790B1 (es) 2015-05-06
CN105188721B (zh) 2017-10-31

Similar Documents

Publication Publication Date Title
MX2015017201A (es) Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga.
MA39986A (fr) Dérivés de purine en tant qu'inhibiteurs de cd73 pour le traitement du cancer
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
MX2016011105A (es) Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos.
HUE056922T2 (hu) 2-szubsztituált amino-naft[1,2-D]imidazol-5-on vegyületek vagy azok gyógyszerészetileg elfogadható sói
SG10201805267UA (en) Piperazine derivatives having multimodal activity against pain
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
GEP20196984B (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
NZ730816A (en) Quinoline carboxamides for use in the treatment of multiple myeloma
EP3806679A4 (en) CAPSULES FOR USE IN PERSONAL VAPORIZERS
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
MX356851B (es) Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos.
IN2013MU01985A (es)
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
MX2013008269A (es) Composicion farmaceutica que comprende derivados de piridona.
IN2013MU01111A (es)
HK1251476A1 (zh) 用於治療癌症的氨基硫羥酸酯化合物或其藥學上可接受的鹽
IN2013MU01226A (es)
MX2014011922A (es) Composicion para el tratamiento de desordenes inflamantorios e inmunes.
IN2013MU01160A (es)
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.
CA2905957C (en) Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
IN2014CH00149A (es)
IN2013MU03838A (es)

Legal Events

Date Code Title Description
FG Grant or registration